T cell targeted immunotherapy for autoimmune disease. Review uri icon

Overview

abstract

  • Much emphasis has been placed on the so-called "biologics" in the treatment of immune disorders within the last few years. Here we discuss the expanding horizon of potential strategies for immunotherapies targeting T lymphocytes as key effectors and regulators of autoimmunity. We review emerging reagents in a variety of animal models and human disorders that may offer new therapeutic options in current or modified iterations.

publication date

  • December 1, 2005

Research

keywords

  • Autoimmune Diseases
  • Immunotherapy
  • T-Lymphocytes

Identity

Scopus Document Identifier

  • 30844473274

Digital Object Identifier (DOI)

  • 10.1080/08916930500418136

PubMed ID

  • 16390811

Additional Document Info

volume

  • 38

issue

  • 8